Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) EVP Patrick R. O’neil sold 1,527 shares of the company’s stock in a transaction dated Wednesday, May 24th. The stock was sold at an average price of $41.70, for a total transaction of $63,675.90. Following the sale, the executive vice president now directly owns 40,355 shares in the […]
StockNews.com started coverage on shares of Ionis Pharmaceuticals (NASDAQ:IONS – Get Rating) in a research report released on Thursday morning. The firm issued a hold rating on the stock. Several other research firms also recently weighed in on IONS. Sanford C. Bernstein initiated coverage on shares of Ionis Pharmaceuticals in a research note on Tuesday, […]
Cartenna Capital LP lessened its stake in shares of Autoliv, Inc. (NYSE:ALV – Get Rating) by 47.8% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 120,000 shares of the auto parts company’s stock after selling 110,000 shares during the period. Autoliv comprises about 1.6% of […]
MQS Management LLC acquired a new stake in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 6,547 shares of the company’s stock, valued at approximately $247,000. A number of other institutional investors and hedge […]
Tweedy Browne Co LLC raised its holdings in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) by 30.0% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 3,541,136 shares of the company’s stock after buying an additional 818,148 shares during the quarter. Ionis Pharmaceuticals accounts for […]